These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17442448)

  • 21. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
    Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
    Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a relationship between c-erbB-1 and c-erbB-2 amplification and protein overexpression in NSCLC?
    Meert AP; Martin B; Verdebout JM; Noël S; Ninane V; Sculier JP
    Lung Cancer; 2005 Mar; 47(3):325-36. PubMed ID: 15713516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
    Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
    J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does c-erbB-2 play a role in the first steps of lung carcinogenesis?
    Meert AP; Martin B; Verdebout JM; Ninane V; Sculier JP
    Anticancer Res; 2005; 25(3B):2005-8. PubMed ID: 16158937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer.
    Meert AP; Martin B; Verdebout JM; Paesmans M; Berghmans T; Ninane V; Sculier JP
    Lung Cancer; 2004 Jun; 44(3):295-301. PubMed ID: 15140542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
    In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas.
    Wu CT; Chang YL; Lee YC
    Hum Pathol; 2005 Oct; 36(10):1108-12. PubMed ID: 16226111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of thymosin beta10 and its role in non-small cell lung cancer.
    Gu Y; Wang C; Wang Y; Qiu X; Wang E
    Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
    Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
    J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways.
    Saviozzi S; Ceppi P; Novello S; Ghio P; Lo Iacono M; Borasio P; Cambieri A; Volante M; Papotti M; Calogero RA; Scagliotti GV
    Cancer Res; 2009 Apr; 69(8):3390-6. PubMed ID: 19351853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.
    Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
    Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
    Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
    Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
    J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression pattern of the scaffold protein IQGAP1 in lung cancer.
    Nakamura H; Fujita K; Nakagawa H; Kishi F; Takeuchi A; Aute I; Kato H
    Oncol Rep; 2005 Mar; 13(3):427-31. PubMed ID: 15706411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
    Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.